What people are saying - Write a review
We haven't found any reviews in the usual places.
P REIZENSTEIN 5 The monitoring of minimal residual disease in patients with
E ULSPERGER and K KARRER 33 Tumor markers for the diagnosis prognosis treatment
J BREARD G MATHE and 47 Abnormal in vitro differentiation of clonogenic Bcells
3 other sections not shown
ACTH acute leukemia acute lymphatic leukemia acute myeloid leukemia adjuvant chemotherapy Adjuvant Therapies AVCF B-cell blood BONADONNA G bone marrow breast cancer breast carcinoma calcitonin CALLA CALLA+ cells Cancer Res carci carcinoembryonic antigen cell lung cancer chemo clin clinical colony cells complete remission correlation cure cytostatic detection effect elevated epithelial evaluation growth Gynec hormone human immunotherapy induced Leuk leukemic cells LH-RH lung cancer lymphoblastic lymphocytes maintenance chemotherapy mammary MATHE G melanoma metastases minimal residual disease minimal residual tumors MlSSET monitoring monoclonal antibody neo-adjuvant ng/ml noma non-Hodgkin lymphoma normal Obstet Oncofrance Oncol Oncology ovarian cancer ovarian carcinoma plasma postoperative prognosis prostate cancer prostatic acid phosphatase prostatic carcinoma radiotherapy receptors relapse RElZENSTElN response sensitivity serum sialic acid small cell carcinoma small cell lung specific stage surgery survival curve Table Therapies of Cancer tissue treatment tumor cells tumor marker values